go to main content
Research Research groups
Overview of research groups within Radboudumc. You can filter the list with regard to keywords, research institutes, research themes and research departments.
Results (36)

Filter results

Bone biochemistry

Nico Sommerdijk’s group focuses on the mechanisms of bone biomineralization in both physiological and pathological situations.

Cerebral circulation and cognition in aging humans

Jurgen Claassen's research group uses various techniques to measure cerebral perfusion, cerebral autoregulation and cognitive activation. These physiological mechanisms play an important role in Alzheimer’s disease, hypertension, and cognitive aging.

Clinical neuroscience in psychiatry

Indira Tendolkar's group focuses the intersection between clinical psychiatry and cognitive neuroscience with a focus on declarative memory. We investigate the adapatation of emotional and neutral memory processes depending on genetic and environmental variablity including somatic challenges.

Clinical pharmacology

Nielka van Erp's research group aims to optimize anticancer treatment in oncology patients by recognizing and addressing interindividual differences and by developing approaches to keep the drugs available for all patients suffering from cancer.

Clinical pharmacology - special populations

Saskia de Wildt's research group uses innovative methods including microdosing and microtracer technology, and physiology-based and population pharmacokinetic modeling, to contribute to a better understanding of the impact of age, disease and genetics on drug disposition in children.

Developmental neuropsychiatry

Jan Buitelaar's research is aimed at a better understanding of neuropsychiatric disorders, such as ADHD, autism, dyslexia and aggression-related disorders, at all levels.

Genetic epidemiology of brain traits and neuropsychiatric disorders

Alejandro Arias Vasquez's goal is to find genes involved in the variation of brain traits as well as for genes involved in the risk of complex neuropsychiatric diseases.

Genomic technologies & immuno-genomics

Alexander Hoischen's group focuses on the application of latest genomic technologies to understand human disease. A particular emphasis is put in the understanding of genetic defects that explain immune diseases, in particular primary immunodeficiencies (PIDs).

Global health priorities

Rob Baltussen's research subgroup supports decision-makers in countries around the world in setting legitimate priorities for universal health coverage.

Magnesium in health and disease

Jeroen de Baaij's research group examines the role of magnesium in health and disease. His team studies the regulation of magnesium handling by the intestine and the kidney, as well as the role of magnesium in disease including diabetes mellitus type 2 and chronic kidney disease.

Malaria research

Teun Bousema's (and Robert Sauerwein's and Taco Kooij's) group focuses on the clinical development of plasmodium falciparum vaccines for control and elimination of malaria.

Medication safety

Cornelis (Kees) Kramers's research group aims to improve medication safety by education of prescribers, transmural interventions and medication optimization.

Molecular Neurogenetics

Hans van Bokhoven's research group investigates the molecular underpinnings of development and functioning of the nervous system and its building blocks, the neurons and other cell types.

Nephropathology research group

Bart Smeets's research group aims to unravel the molecular processes underlying kidney regeneration and to identify new treatment targets to attenuate kidney disease progression.

Neurological movement disorders

Bas Bloem's first research line aims at studying human motor control in health and disease, in particular patients with neurological movement disorders. A second main interest is in health care innovation, aiming to develop and scientifically evaluate patient-centred collaborative care.

Orthopaedic research lab

Nico Verdonschot's research group focuses on the external loads applied to the musculoskeletal system, and how these loads influence the reconstructions.

Personalized pharmaceutical care

Bart van den Bemt's research group is a (inter)nationally recognized group on adequate medication use, medication adherence, medication waste and (cost-)effective pharmacotherapy.

Pharmaco­genomics

Marieke Coenen's research group performs pharmacogenetic research, from gene-finding to clinical implementation studies with a focus on paediatric (oncology) and psychiatry and inflammatory bowel disease.

Pharmacology and toxicology

Frans Russel's research group develops computational models that predict fetal-maternal drug exposure in pregnancy and brain penetration of drugs in adults and children.

Pharmacology of antibiotic agents

Roger Brüggemann's and Nynke Jager's research group investigates the pharmacokinetics and dynamics of antimicrobial agents. Research ranges from in vitro experiments to clinical trials in special patient populations. The main aim is to define the optimal dose for each individual patient.

Pharmacology of anti-tuberculosis drugs

Rob Aarnoutse's research group investigates the pharmacology of existing and new drugs for tuberculosis, using a translational approach that extends from molecular pharmacology to clinical pharmacology studies and to clinical trials, supported by advanced laboratory and modeling techniques.

Pharmacology of antiviral drugs (HIV and HCV)

David Burger's group investigates the pharmacology of antiviral drugs for the treatment of HIV and hepatitis C in special patient population such as pregnant women, children and hepatically impaired patients. We also study drug-drug interactions and the impact on exposure of new drug-formulations.

Plastic surgery research & Innovation lab

Dietmar Ulrich's research group is continuously aiming to find the latest and best methods to treat patients that visit the department of Plastic Surgery.

Radboud applied pharmacome­trics

Rob ter Heine's and Elin Svensson's research group develops and applies mathematical models describing clinical pharmacology processes to interpret clinical trial data, perform clinical trial simulations, support drug development decisions, and optimize therapy in the clinic.

Regenerative biomaterials

Sander Leeuwenburgh's research group focuses on developing advanced tissue regenerative therapies, utilizing biomaterials either or not combined with biological components. These therapies exploit biomaterial properties, patient-derived cells or therapeutic molecules to empower their functionality.

Regulation of epithelial electrolyte transport

Jenny van der Wijst's research group studies the regulation of epithelial ion transport, with a fundamental focus on the electrophysiological analysis combined with the biochemistry of ion channels, membrane transporters and cell signaling.

Renal electrolyte handling

René Bindels' research group studies the regulation of ion transport processes in kidney and small intestine in health and disease. Current projects involve the molecular mechanisms underlying rare tubulopathies and the regulation of the newly identified calcium, magnesium and sodium transporters.

Research in primary care

Pim Assendelft's research group aims to improve healthcare, from a primary care and transmural perspective.

Sleep and memory

Martin Dresler's research centers on the cognitive neuroscience of sleep and memory, using behavioral, endocrinological, pharmacological, electrophysiological and neuroimaging approaches in healthy subjects and psychiatric and neurological patients.

Statistical imaging neuroscience

Christian Beckmann's research group researches analytical approaches for the analysis of functional neuroimaging data

Synchronization in neural systems

Michael Cohen's research group focuses on how circuits in the brain process sensory and cognitive information, and transmit that information across brain regions.

Targeted nanomedicines

Roland Brock’s group focuses on the targeted delivery of molecules such as oligonucleotides, toxins and photosensitizers to modulate cell function and/or induce cell death. This research involves fundamental studies of formulation strategies and uptake mechanisms as well as preclinical applications.

Translational cardiovascular research

Gerard Rongen's research group studies the impact of nucleoside transport inhibitors on vascular actions of adenosine and ischemia reperfusion injury.

Translational CRC research

Daniele Tauriello's, Henk Verheul's, Nielka van Erp's and Iris Nagtegaal's research group is a cross-disciplinary research collaboration of four Radboudumc groups, with the aim of advancing clinical translation for colorectal cancer.

Tuberculosis: From basic biology to population control

Reinout van Crevel's research group integrates patient studies and laboratory sciences to understand the biology of tuberculosis (TB) transmission, infection and disease, including its severest form: meningitis.

Understanding genetic disease

Han Brunner's research group studies all genetic aspects with a focus on patient observation, and the translation of clinical questions in short term research projects.

  • Wapen van Radboudumc